Pituitary tumors are primarily benign adenomas originating within the sella turcica at the base of the brain. Characterized by mass effect compression on the optic chiasm or systemic hormonal dysregulation, their evaluation and care require high-resolution MRI, multi-axis endocrine testing, and specialized endoscopic transsphenoidal microsurgery.
Overview of Pituitary Tumors
Pituitary tumors are abnormal growths arising from the pituitary gland, a small endocrine organ located within the sella turcica at the base of the brain. Most are benign adenomas, but their size and hormonal activity can lead to significant clinical effects. They represent a major category among primary brain tumors.
Pituitary tumors are generally classified as:
- Functioning adenomas: Secrete excess hormones such as prolactin, growth hormone, or ACTH.
- Non-functioning adenomas: Do not secrete clinically significant hormones but may cause symptoms through local mass effect.
Due to their proximity to the optic chiasm, these tumors frequently produce pituitary tumors headaches and progressive visual disturbances.
Clinical Features
Hormonal Effects
- Hyperprolactinemia: Galactorrhea, menstrual irregularities in women, hypogonadism in men.
- Excess growth hormone: Acromegaly in adults, gigantism in pediatric patients. Read about pediatric brain tumors.
- Excess ACTH: Cushing’s disease with central obesity, hypertension, and glucose intolerance.
Mass Effects
- Persistent, dull, or retro-orbital headaches due to dural stretch (pituitary tumors headaches).
- Visual field defects, classically bitemporal hemianopia from chiasmal compression.
- Cranial nerve palsies (CN III, IV, VI) in large adenomas invading the cavernous sinus.
Systemic & Endocrine Manifestations
Fatigue, weakness, unexplained weight changes, and panhypopituitarism from compression of normal pituitary tissue. Hormonal imbalances frequently lead to menstrual irregularities, infertility, metabolic disturbances, or secondary adrenal insufficiency.
Histopathology of Pituitary Tumors
Histological examination reveals uniform cells with round to oval nuclei, sparse stroma, and a disrupted reticulin network. Immunohistochemistry confirms hormone lineage:
1. Functioning Adenomas
- Prolactinomas: Lactotroph-derived tumors; prolactin-secreting tumors, known as prolactinomas, are the most prevalent type of pituitary adenoma.
- Somatotroph adenomas: Secrete growth hormone, causing acromegaly or gigantism.
- Corticotroph adenomas: Secrete ACTH, driving Cushing’s disease.
- Thyrotroph adenomas: Rare TSH-secreting lesions leading to hyperthyroidism.
- Gonadotroph adenomas: May synthesize FSH or LH, though often silent.
2. Non-Functioning & Atypical Variants
- Non-functioning adenomas: Typically null-cell or silent gonadotroph adenomas causing mass effect.
- Atypical adenomas: Characterized by elevated mitotic activity, high Ki-67 labeling index, and p53 nuclear positivity.
- Pituitary carcinoma: Extremely rare malignancies defined strictly by craniospinal or systemic metastasis.
Diagnostic Evaluation
Ophthalmologic & Neurological Assessment
Formal visual field testing (perimetry) to identify bitemporal hemianopia and optic nerve compression, alongside cranial nerve and motor evaluation.
Endocrine Blood Tests
Serum hormonal panels for pituitary tumors to measure prolactin, GH, IGF-1, ACTH, morning cortisol, TSH, free T4, FSH, and LH, as well as screening for electrolyte disturbances.
Radiological Imaging
High-resolution pituitary MRI with fine sellar cuts is the gold standard, delineating tumor dimensions, optic chiasm displacement, and cavernous sinus extension. CT is reserved for bone detail or MRI contraindications.
Treatment Approaches
Management requires a multidisciplinary team integrating endocrinology, neurosurgery, neuroradiology, and ophthalmology:
1. Medical Therapy
First-line therapy for prolactinomas consists of dopamine agonists (cabergoline, bromocriptine). Somatostatin analogs or GH receptor antagonists are utilized for acromegaly, and lifelong hormone replacement is instituted for endocrine deficiencies.
2. Endoscopic Surgical Intervention
Endoscopic transsphenoidal surgery is the preferred approach for symptomatic, non-functioning, or medically refractory pituitary adenomas. Pituitary tumor before and after images often demonstrate complete sellar decompression and prompt relief of optic chiasm compression.
3. Radiotherapy & Surveillance
Stereotactic radiosurgery or fractionated radiotherapy is employed for residual, recurrent, or aggressive adenomas to control tumor growth while sparing surrounding neurovascular structures. Postoperative MRI and routine blood tests for pituitary tumors are mandatory for long-term monitoring.
Prognosis
Most pituitary tumors are benign, and long-term outcomes are favorable with timely multidisciplinary care. Prognosis depends on tumor subtype, functional status, initial size, and completeness of surgical resection. Recurrence is possible in macroadenomas or atypical variants, necessitating periodic MRI monitoring and hormonal follow-up.
Conclusion
Pituitary tumors are complex lesions with both hormonal and mass-related effects. Early recognition of pituitary tumors symptoms, including headaches, visual changes, and endocrine disturbances, is vital. Management requires a multidisciplinary team, integrating surgery, medical therapy, radiotherapy, and hormone replacement. Monitoring through imaging and laboratory tests ensures long-term tumor control and optimal quality of life. Pituitary tumor before and after assessments are key to evaluating treatment success and guiding further care.
Frequently Asked Questions
What is a pituitary tumor?
A pituitary tumor is a mass developing in the pituitary gland at the base of the brain. Most are benign adenomas that either produce excess hormones or cause mass effect on surrounding structures.
What is the difference between functioning and non-functioning pituitary adenomas?
Functioning adenomas actively secrete excess hormones (such as prolactin, GH, or ACTH), leading to systemic endocrine syndromes. Non-functioning adenomas do not secrete hormones and present primarily with headaches or vision loss.
How do pituitary tumors affect vision?
As a pituitary macroadenoma grows out of the sella turcica, it presses upward on the optic chiasm, classically causing bitemporal hemianopia (loss of peripheral vision in both eyes).
What is the primary treatment for prolactinomas?
Unlike most brain tumors, prolactinomas are primarily treated with medical therapy using dopamine agonists (such as cabergoline), which shrink the tumor and normalize prolactin levels without surgery.
What is endoscopic transsphenoidal surgery?
It is a minimally invasive surgical technique where neurosurgeons remove the pituitary tumor through the nasal passages and sphenoid sinus using an endoscope, avoiding a cranial incision.
Can a pituitary tumor come back after surgery?
Yes. Recurrence can occur, especially if residual tumor cells remain attached to the cavernous sinus or carotid arteries. Regular follow-up MRI scans and hormone blood tests are essential.
Updated: September 1, 2026 | Editor: info@ilhanelmaci.com.tr ©️ 2026 Prof. Dr. İlhan Elmacı. This content may not be copied or republished without permission.